Human IFN-γ T cell ELISPOT kit - 2-plate

SKU
CT230-B2
All-inclusive ELISPOT kit with reagents and plates (192 determinations).
Format
2-plate
Price
€ 485
Reactivity
Human
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT kits provide a complete, ready-to-use solution for reliable, high-performance ELISPOT assays. Each kit includes all essential components: coating and detection antibodies, streptavidin-HRP, TMB substrate, blocking stock solution, dilution buffer, Tween-20, and high-quality PVDF ELISPOT plates with lids and adhesive plate covers.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Image
Image

References

Authors, et al. Title Journal Year Volume Pages
Jeroen Gerrits T-cell reactivity during tapering of immunosuppression to low-dose monotherapy prednisolone in HLA-identical living-related renal transplant recipients Transplantation 2009 87 907-14
Jeroen Gerrits Non-HLA T-cell reactivity during the first year after HLA-identical living-related kidney transplantation Clin Transplant 2009 23 740-7
Chantal de Koning Clinimetric evaluation of methods to measure muscle functioning in patients with non-specific neck pain: a systematic review BMC Musculoskelet Disord 2008 9 142
Ania Skowera CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope J Clin Invest 2008 118 3390-402
Jeroen Gerrits Donor-reactive cytokine profiles after HLA-identical living-related kidney transplantation Nephrol Dial Transplant 2008 23 2016-23
V Huurman Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes Clin Exp Immunol 2008 152 488-97
Srinath Sanda Islet antigen specific IL-10+ immune responses but not CD4+CD25+FoxP3+ cells at diagnosis predict glycemic control in type 1 diabetes Clin Immunol 2008 127 138-43
Emanuela Martinuzzi The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment Diabetes 2008 57 1312-20
Emanuela Martinuzzi Serum-free culture medium and IL-7 costimulation increase the sensitivity of ELISpot detection J Immunol Methods 2008 333 61-70
Nicole van Besouw After discontinuation of calcineurin inhibitors, tapering of mycophenolate mofetil further impairs donor-directed cytotoxicity Clin Transplant 2008 22 129-35